JP2001504331A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001504331A5 JP2001504331A5 JP1998521150A JP52115098A JP2001504331A5 JP 2001504331 A5 JP2001504331 A5 JP 2001504331A5 JP 1998521150 A JP1998521150 A JP 1998521150A JP 52115098 A JP52115098 A JP 52115098A JP 2001504331 A5 JP2001504331 A5 JP 2001504331A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9623236.8A GB9623236D0 (en) | 1996-11-07 | 1996-11-07 | Notch |
| GB9623236.8 | 1996-11-07 | ||
| GBGB9715674.9A GB9715674D0 (en) | 1997-07-24 | 1997-07-24 | Notch |
| GB9715674.9 | 1997-07-24 | ||
| GB9719350.2 | 1997-09-11 | ||
| GBGB9719350.2A GB9719350D0 (en) | 1997-09-11 | 1997-09-11 | Notch |
| PCT/GB1997/003058 WO1998020142A1 (en) | 1996-11-07 | 1997-11-06 | Notch |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001504331A JP2001504331A (ja) | 2001-04-03 |
| JP2001504331A5 true JP2001504331A5 (enExample) | 2005-05-12 |
| JP4339406B2 JP4339406B2 (ja) | 2009-10-07 |
Family
ID=27268574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52115098A Expired - Fee Related JP4339406B2 (ja) | 1996-11-07 | 1997-11-06 | 免疫療法に使用する医薬の製造におけるＳｅｒｒａｔｅまたはＤｅｌｔａの使用 |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP0942998B1 (enExample) |
| JP (1) | JP4339406B2 (enExample) |
| KR (1) | KR100393234B1 (enExample) |
| CN (2) | CN1524583A (enExample) |
| AT (1) | ATE299184T1 (enExample) |
| AU (1) | AU736361B2 (enExample) |
| BG (1) | BG103444A (enExample) |
| CA (1) | CA2271248C (enExample) |
| CZ (1) | CZ295997B6 (enExample) |
| DE (1) | DE69733695T2 (enExample) |
| ES (1) | ES2243986T3 (enExample) |
| GB (2) | GB2335194B (enExample) |
| GE (1) | GEP20043390B (enExample) |
| IL (1) | IL129531A0 (enExample) |
| NO (1) | NO992196L (enExample) |
| NZ (1) | NZ335549A (enExample) |
| PL (1) | PL333302A1 (enExample) |
| RO (1) | RO120850B1 (enExample) |
| TR (1) | TR199901000T2 (enExample) |
| WO (1) | WO1998020142A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU723939B2 (en) | 1995-06-28 | 2000-09-07 | Imperial Cancer Research Technology Ltd | Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| US5780300A (en) * | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
| GB9824045D0 (en) * | 1998-11-03 | 1998-12-30 | European Molecular Biology Lab Embl | Regulator protein |
| GB9827604D0 (en) * | 1998-12-15 | 1999-02-10 | Lorantis Ltd | Methods of immunosuppression |
| GB9927328D0 (en) * | 1999-11-18 | 2000-01-12 | Lorantis Ltd | Immunotherapy |
| GB0019242D0 (en) * | 2000-08-04 | 2000-09-27 | Lorantis Ltd | Assay |
| CA2422538C (en) * | 2000-09-22 | 2012-06-19 | Genentech, Inc. | Notch receptor agonists and uses |
| US6689744B2 (en) | 2000-09-22 | 2004-02-10 | Genentech, Inc. | Notch receptor agonists and uses |
| RU2179862C1 (ru) * | 2000-12-26 | 2002-02-27 | Общество с ограниченной ответственностью Научно-производственный центр "МедБиоСпектр" | Лекарственное средство для предотвращения отторжения трансплантата, моноклональное антитело к cd3-антигену т-лимфоцитов человека, гибридома и способ лечения больных, имеющих реакцию острого отторжения трансплантата после пересадки почки |
| GB0118155D0 (en) * | 2001-07-25 | 2001-09-19 | Lorantis Ltd | Superantigen |
| JP2004537314A (ja) * | 2001-07-25 | 2004-12-16 | ロランティス リミテッド | ノッチシグナル伝達モジュレーターを検出する方法 |
| GB0123379D0 (en) * | 2001-09-28 | 2001-11-21 | Lorantis Ltd | Modulators |
| ES2431518T3 (es) * | 2002-02-06 | 2013-11-26 | Sanbio Inc. | Método de diferenciación/inducción de células estromales de médula ósea en células nerviosas por transferencia del gen Notch |
| EP1492816A2 (en) * | 2002-04-05 | 2005-01-05 | Lorantis Limited | Modulators of the notch signalling pathway and uses thereof in medical treatment |
| AU2003255735A1 (en) * | 2002-08-03 | 2004-02-23 | Lorantis Limited | Conjugate of notch signalling pathway modulators and their use in medical treatment |
| GB0218879D0 (en) * | 2002-08-14 | 2002-09-25 | Lorantis Ltd | Medical treatment |
| GB0220658D0 (en) * | 2002-09-05 | 2002-10-16 | Lorantis Ltd | Immunotherapy |
| AU2003269268A1 (en) * | 2002-10-09 | 2004-05-04 | Lorantis Limited | Modulation of immune function |
| WO2004060262A2 (en) * | 2003-01-07 | 2004-07-22 | Lorantis Limited | Modulators of notch signalling for use in immunotherpapy |
| GB0300428D0 (en) * | 2003-01-09 | 2003-02-05 | Lorantis Ltd | Medical treatment |
| WO2004064863A1 (en) * | 2003-01-23 | 2004-08-05 | Lorantis Limited | Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| GB0303663D0 (en) * | 2003-02-18 | 2003-03-19 | Lorantis Ltd | Assays and medical treatments |
| ATE474593T1 (de) * | 2003-03-21 | 2010-08-15 | Celldex Therapeutics Ltd | Behandlung von allergischen erkrankungen unter verwendung eines modulators des notch signaling pathway |
| WO2004083372A2 (en) * | 2003-03-21 | 2004-09-30 | Lorantis Limited | Modulators of the notch signaling pathway immobilized on particles for modifying immune responses |
| GB0307472D0 (en) * | 2003-04-01 | 2003-05-07 | Lorantis Ltd | Medical treatment |
| WO2007145840A2 (en) | 2006-06-13 | 2007-12-21 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| AU2008209482B2 (en) | 2007-01-24 | 2014-05-01 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| CA2729602A1 (en) | 2008-07-08 | 2010-01-14 | Oncomed Pharmaceuticals, Inc. | Notch1 receptor binding agents and methods of use thereof |
| JP2012500791A (ja) * | 2008-08-22 | 2012-01-12 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | Ｎｏｔｃｈ３シグナル伝達のデコイインヒビターとしてのヒトｎｏｔｃｈ３に基づく融合タンパク質 |
| DE112010000371A5 (de) | 2009-02-16 | 2012-09-06 | Deutsches Rheuma-Forschungszentrum Berlin | Verwendung von Notch-Regulatoren zur Modulation der Immunantwort durch Induktion/Suppression von Interleukin-22 |
| US8623358B2 (en) | 2009-08-29 | 2014-01-07 | Abbvie Inc. | Therapeutic DLL4 binding proteins |
| EP2542582A4 (en) | 2010-03-02 | 2013-12-04 | Abbvie Inc | THERAPEUTIC PROTEINS LINKING TO DLL4 |
| CN106692193B (zh) * | 2011-04-06 | 2021-01-05 | 桑比欧公司 | 用于调节外周免疫功能的方法和组合物 |
| CN107056930A (zh) * | 2011-11-16 | 2017-08-18 | 昂考梅德药品有限公司 | 编码突变的人notch受体的多核苷酸 |
| US20150140043A1 (en) * | 2012-05-10 | 2015-05-21 | Institut National De La Sante De La Recherche Medical (Inserm) | Immunomodulatory methods using notch agonists |
| KR101573650B1 (ko) * | 2015-02-04 | 2015-12-01 | 성균관대학교산학협력단 | Hcmv 바이러스 복제 억제용 조성물 |
| BR112021003830A2 (pt) * | 2018-08-28 | 2021-07-20 | Fred Hutchinson Cancer Research Center | métodos e composições para terapia celular t adotiva incorporando sinalização notch induzida |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL101728A (en) * | 1991-05-03 | 2007-08-19 | Univ Yale | Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them |
| US5869282A (en) * | 1991-12-11 | 1999-02-09 | Imperial Cancer Research Technology, Ltd. | Nucleotide and protein sequences of the serrate gene and methods based thereon |
| US5786158A (en) * | 1992-04-30 | 1998-07-28 | Yale University | Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| WO1995021258A1 (en) * | 1994-02-01 | 1995-08-10 | United States Of America, Represented By The Secretary, Department Of Health And Human Services | Fusion proteins that include antibody and nonantibody portions |
| US5780300A (en) * | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
| ATE319827T1 (de) * | 1995-11-17 | 2006-03-15 | Asahi Chemical Ind | Polypeptid, das die differenzierung unterdrueckt |
-
1997
- 1997-11-06 EP EP97911353A patent/EP0942998B1/en not_active Expired - Lifetime
- 1997-11-06 PL PL97333302A patent/PL333302A1/xx unknown
- 1997-11-06 EP EP05076507A patent/EP1616958A3/en not_active Withdrawn
- 1997-11-06 AU AU48765/97A patent/AU736361B2/en not_active Ceased
- 1997-11-06 DE DE69733695T patent/DE69733695T2/de not_active Expired - Lifetime
- 1997-11-06 CN CNA2004100055918A patent/CN1524583A/zh active Pending
- 1997-11-06 CN CNB971811598A patent/CN1160371C/zh not_active Expired - Fee Related
- 1997-11-06 RO RO99-00524A patent/RO120850B1/ro unknown
- 1997-11-06 JP JP52115098A patent/JP4339406B2/ja not_active Expired - Fee Related
- 1997-11-06 WO PCT/GB1997/003058 patent/WO1998020142A1/en not_active Ceased
- 1997-11-06 GB GB9910276A patent/GB2335194B/en not_active Revoked
- 1997-11-06 KR KR10-1999-7004079A patent/KR100393234B1/ko not_active Expired - Fee Related
- 1997-11-06 CA CA002271248A patent/CA2271248C/en not_active Expired - Fee Related
- 1997-11-06 CZ CZ19991639A patent/CZ295997B6/cs not_active IP Right Cessation
- 1997-11-06 ES ES97911353T patent/ES2243986T3/es not_active Expired - Lifetime
- 1997-11-06 AT AT97911353T patent/ATE299184T1/de not_active IP Right Cessation
- 1997-11-06 GB GB0023691A patent/GB2353094B/en not_active Expired - Fee Related
- 1997-11-06 NZ NZ335549A patent/NZ335549A/en unknown
- 1997-11-06 GE GE3531A patent/GEP20043390B/en unknown
- 1997-11-06 IL IL12953197A patent/IL129531A0/xx unknown
- 1997-11-06 TR TR1999/01000T patent/TR199901000T2/xx unknown
-
1999
- 1999-05-05 NO NO992196A patent/NO992196L/no unknown
- 1999-05-28 BG BG103444A patent/BG103444A/xx unknown